Cyclophosphamide treatment in active multiple sclerosis

ConclusionsCYC continues to be a valid therapeutic option, especially in regions with limited access to high-efficiency therapies particularly in patients with high relapsing activity and malignant course.
Source: Neurological Sciences - Category: Neurology Source Type: research